Gül, A. B. Et Al. 2023. Prevention of Gestational Alloimmune Liver Disease by Intravenous Immunoglobulin Administration in the Second Trimester: A Presentation of Two Cases. Journal of Clinical Obstetrics and Gynecology , vol.33, no.3 , 191-194.

Gül, A. B., Emine, K., Hülya, K., Arzu, A., Özlem, E., & Cem Yaşar, S., (2023). Prevention of Gestational Alloimmune Liver Disease by Intravenous Immunoglobulin Administration in the Second Trimester: A Presentation of Two Cases. Journal of Clinical Obstetrics and Gynecology , vol.33, no.3, 191-194.

Gül, Alkan Et Al. "Prevention of Gestational Alloimmune Liver Disease by Intravenous Immunoglobulin Administration in the Second Trimester: A Presentation of Two Cases," Journal of Clinical Obstetrics and Gynecology , vol.33, no.3, 191-194, 2023

Gül, Alkan B. Et Al. "Prevention of Gestational Alloimmune Liver Disease by Intravenous Immunoglobulin Administration in the Second Trimester: A Presentation of Two Cases." Journal of Clinical Obstetrics and Gynecology , vol.33, no.3, pp.191-194, 2023

Gül, A. B. Et Al. (2023) . "Prevention of Gestational Alloimmune Liver Disease by Intravenous Immunoglobulin Administration in the Second Trimester: A Presentation of Two Cases." Journal of Clinical Obstetrics and Gynecology , vol.33, no.3, pp.191-194.

@article{article, author={Alkan Bülbül Gül Et Al. }, title={Prevention of Gestational Alloimmune Liver Disease by Intravenous Immunoglobulin Administration in the Second Trimester: A Presentation of Two Cases}, journal={Journal of Clinical Obstetrics and Gynecology}, year=2023, pages={191-194} }